Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Characterization of the in vitro inhibitory potential of the oligonucleotide imetelstat on human cytochrome P450 enzymes with predictions of in vivo drug-drug interactions.

Kazmi F, Sensenhauser C, Greway T.

Drug Metab Dispos. 2018 Nov 2. pii: dmd.118.084103. doi: 10.1124/dmd.118.084103. [Epub ahead of print]

PMID:
30389730
2.

Quantitative analysis of imetelstat in plasma with LC-MS/MS using solid-phase or hybridization extraction.

Dillen L, Sips L, Greway T, Verhaeghe T.

Bioanalysis. 2017 Dec;9(23):1859-1872. doi: 10.4155/bio-2017-0145. Epub 2017 Dec 5.

3.

Nonclinical safety assessment of a synthetic peptide thrombopoietin agonist: effects on platelets, bone homeostasis, and immunogenicity and the implications for clinical safety monitoring of adverse bone effects.

Knight E, Eichenbaum G, Hillsamer V, Greway T, Tonelli A, Han-Hsu H, Zakszewski C, Yurkow E, Shukla U, End D, Louden C.

Int J Toxicol. 2011 Aug;30(4):385-404. doi: 10.1177/1091581811404708.

PMID:
21832269
4.

Postmortem redistribution of fentanyl in the rabbit blood.

Ceelen L, De Zwart L, Voets M, Hillewaert V, Monbaliu J, Teuns G, Coussement W, Greway T.

Am J Forensic Med Pathol. 2012 Jun;33(2):119-23. doi: 10.1097/PAF.0b013e3181fbbb49.

PMID:
21389904
5.

Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin.

Jolling K, Perez Ruixo JJ, Hemeryck A, Vermeulen A, Greway T.

Eur J Pharm Sci. 2005 Apr;24(5):465-75.

PMID:
15784336
6.

Population pharmacokinetic analysis of pegylated human erythropoietin in rats.

Jolling K, Ruixo JJ, Hemeryck A, Piotrovskij V, Greway T.

J Pharm Sci. 2004 Dec;93(12):3027-38.

PMID:
15503315

Supplemental Content

Loading ...
Support Center